PharmaOnco™ NK Cell Differentiation Kit has been developed for the in vitro culture and expansion of human natural killer (NK) cells expressing CD56 in Serum-Free (SF) conditions without the use of problematic feeder cells. Using this kit, CD34⁺ hematopoietic progenitor cells are first generated from human pluripotent stem cells (hPSCs); these can then be differentiated to NK cells.
Features
Serum-Free (SF) formulation
Applications
Cell Culture, Differentiation, Expansion
Comment
The products in this kit are also available for individual sale. Please contact us for your requirements.
Detection Method
Flow Cytometry
Sample Type
Cells
Research Areas
Immunology, Stem Cell Biology, Cell Therapy Research
Size
1 kit
Components
PharmaOnco™ Hematopoietic EB Basal Medium, 120 mL PharmaOnco™ Hematopoietic EB Supplement A, 265 μL PharmaOnco™ Hematopoietic EB Supplement B, 7 mL PharmaOnco™ Hematopoietic Cells Medium II (SF), 100 mL PharmaOnco™ Lymphoid Progenitor Expansion Supplement (10X), 5 mL PharmaOnco™ Lymphoid Differentiation Coating Material (100X), 0.25 mL PharmaOnco™ NK Cell Differentiation Supplement (100X), 0.5 mL
Material not included
UM-729
Cell Background
NK Cells
Species
Human
Format
Liquid
Precaution of Use
When handling biohazardous materials such as human cells, safe laboratory procedures should be followed and protective clothing should be worn.
Storage
Store at -20°C
Expiry Date
Stable as supplied until expiry date on label.
Note
Tested for sterility
Restrictions
Restrictions for research use only. Intended for use by laboratory professionals.